Pascal Biosciences And SoRSE Team Up On Cannabis Cancer Therapy

Biotechnology company Pascal Biosciences Inc. (TSX.V: PAS) has partnered with SoRSE Technology Corp over an early-stage study of using cannabis as a treatment for cancer.

Pascal CEO Patrick Gray expects that Pascal would finalize Phase-1A testing of the cannabis-based cancer therapy by the end of the 15-month collaboration with the Seattle-based SoRSE.

Howard Lee, SoRSE’s CEO, said that they would fund research expenses, Reuters …

Full story available on Benzinga.com

More Pascal Biosciences And SoRSE Team Up On Cannabis Cancer Therapy